Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis

J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e394-e396. doi: 10.1111/jdv.17177. Epub 2021 Mar 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Dermatitis, Atopic* / drug therapy
  • Eczema*
  • Eosinophilia / chemically induced*
  • Humans
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab